CureGenetics Funding: $96M Raised, Series B (2024)

CureGenetics funding overview

CureGenetics is based in San Diego. CureGenetics has raised $96M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in March 2024. The round record for CureGenetics runs through 2024; nothing later has been disclosed. Investors on record include Formic Ventures, Qiming Venture Partners, Bill Gates, Scott Becker, Ascendin Investment, CTS Capital. 6 distinct backers are named across the disclosed rounds.

CureGenetics at a glance

Total raised: $96M
Latest round: Series B
Latest round date: March 2024
Headquarters: San Diego
Notable investors: Formic Ventures, Qiming Venture Partners, Bill Gates, Scott Becker, Ascendin Investment, CTS Capital

Frequently asked about CureGenetics funding

How much has CureGenetics raised?: CureGenetics has raised $96M in total disclosed funding across the rounds on record.
Who has invested in CureGenetics?: Formic Ventures, Qiming Venture Partners, Bill Gates, Scott Becker, Ascendin Investment, CTS Capital are named among the investors backing CureGenetics.
What was the latest CureGenetics funding round?: The most recent disclosed round is a Series B, announced in March 2024.
Where is CureGenetics based?: CureGenetics is based in San Diego.
When did CureGenetics last raise?: The last disclosed CureGenetics round closed in March 2024 at Series B.

CureGenetics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.

CureGenetics Funding: $96M Raised, Series B (2024)

CureGenetics funding overview

CureGenetics at a glance

Frequently asked about CureGenetics funding

Companies related to CureGenetics (20)

Browse related funding lists (7)